Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

51.51
Delayed Data
As of 3:59pm ET
 +0.26 / +0.51%
Today’s Change
33.36
Today|||52-Week Range
68.68
+11.18%
Year-to-Date

Today’s Trading

Previous close51.25
Today’s open54.44
Day’s range50.85 - 54.98
Volume37,937
Average volume (3 months)616,329
Market cap$3.6B
Data as of 3:59pm ET, 06/06/2023

Growth & Valuation

Earnings growth (last year)-51.09%
Earnings growth (this year)+19.33%
Earnings growth (next 5 years)+86.06%
Revenue growth (last year)+3.39%
P/E ratioNM
Price/Sales8.92
Price/Book10.10

Competitors

 Today’s
change
Today’s
% change
CYTKCytokinetics Inc-0.29-0.76%
----
FOLDAmicus Therapeutics ...+0.30+2.46%
RETAReata Pharmaceutical...+1.85+2.01%
Data as of 4:00pm ET, 06/06/2023

Financials

Next reporting dateAugust 3, 2023
EPS forecast (this quarter)-$2.07
Annual revenue (last year)$363.3M
Annual profit (last year)-$707.4M
Net profit margin-194.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Novato, California

Forecasts